M&A Deal Summary |
|
---|---|
Date | 2008-09-16 |
Target | J.B. Laboratories |
Sector | Life Science |
Buyer(s) | Perrigo Company |
Deal Type | Add-on Acquisition |
Deal Value | 44M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1887 |
Sector | Life Science |
Employees | 9,140 |
Revenue | 4.7B USD (2023) |
Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API), as well as receives royalties from Multiple Sclerosis drug Tysabri®. The company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market and an industry leader in pharmaceutical technologies. Perrigo Company was founded in 1887 and is based in Dublin, Ireland.
DEAL STATS | # |
---|---|
Overall | 7 of 31 |
Sector (Life Science) | 3 of 7 |
Type (Add-on Acquisition) | 6 of 23 |
State (Michigan) | 1 of 2 |
Country (United States) | 3 of 18 |
Year (2008) | 2 of 4 |
Size (of disclosed) | 18 of 23 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2008-01-09 |
Galpharm Healthcare
Barnsley, United Kingdom Galpharm Healthcare Ltd. it the supplier of over-the-counter (OTC) store brand pharmaceutical products sold by super markets, drug stores and pharmacies in the U.K |
Buy | $86M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2008-10-06 |
Laboratorios Diba S.A.
Guadalajara, Mexico Laboratorios Diba S.A. manufacture and market pharmaceutical products that contribute to health improvement, ensuring total satisfaction of customers and consumers, creating jobs and achieving collective and corporate profits. |
Buy | $25M |